Surf Therapeutics is developing a patented, non-invasive ultrasound neuromodulation platform aimed at treating chronic inflammatory disorders, specifically rheumatoid arthritis. The company is clinical-stage and led by CEO Nishant Doctor. It seeks to safely bring this non-invasive therapy into the home to provide scalable relief without drugs or surgery. The firm is based in Austin, TX. The company reported it will use newly received investment capital to expand its development efforts. No revenue, user metrics, past funding rounds, or valuation figures were disclosed in the article.

Total raised

$6M

Funding rounds

2

Latest round

Seed

Latest activity

Mar 2026